Unexpectedly, a significant proportion of ATRX-altered gliomas (18% in the TCGA cohort and 28% in our local cohort) were not classic IDH-mutant astrocytomas or histone-mutant gliomas. Here, ATRX is linked to astrocytoma (excluding glioblastoma).